FR2323M - New drug, in particular for the treatment of follicle-stimulating hyperactivity. - Google Patents

New drug, in particular for the treatment of follicle-stimulating hyperactivity.

Info

Publication number
FR2323M
FR2323M FR905184A FR905184A FR2323M FR 2323 M FR2323 M FR 2323M FR 905184 A FR905184 A FR 905184A FR 905184 A FR905184 A FR 905184A FR 2323 M FR2323 M FR 2323M
Authority
FR
France
Prior art keywords
hyperactivity
follicle
stimulating
treatment
new drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR905184A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR905184A priority Critical patent/FR2323M/en
Application granted granted Critical
Publication of FR2323M publication Critical patent/FR2323M/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
FR905184A 1962-04-25 1962-07-26 New drug, in particular for the treatment of follicle-stimulating hyperactivity. Active FR2323M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR905184A FR2323M (en) 1962-04-25 1962-07-26 New drug, in particular for the treatment of follicle-stimulating hyperactivity.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR895563A FR1380415A (en) 1962-04-25 1962-04-25 Process for the preparation of steroids having a double bond in position 5 (10)
FR905184A FR2323M (en) 1962-04-25 1962-07-26 New drug, in particular for the treatment of follicle-stimulating hyperactivity.

Publications (1)

Publication Number Publication Date
FR2323M true FR2323M (en) 1964-02-10

Family

ID=8777621

Family Applications (2)

Application Number Title Priority Date Filing Date
FR895563A Expired FR1380415A (en) 1962-04-25 1962-04-25 Process for the preparation of steroids having a double bond in position 5 (10)
FR905184A Active FR2323M (en) 1962-04-25 1962-07-26 New drug, in particular for the treatment of follicle-stimulating hyperactivity.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
FR895563A Expired FR1380415A (en) 1962-04-25 1962-04-25 Process for the preparation of steroids having a double bond in position 5 (10)

Country Status (7)

Country Link
AT (1) AT253696B (en)
BR (1) BR6348576D0 (en)
CH (1) CH414609A (en)
DK (1) DK105336C (en)
ES (1) ES287334A1 (en)
FR (2) FR1380415A (en)
GB (1) GB1015013A (en)

Also Published As

Publication number Publication date
ES287334A1 (en) 1963-07-16
DK105336C (en) 1966-09-19
AT253696B (en) 1967-04-25
GB1015013A (en) 1965-12-31
FR1380415A (en) 1964-12-04
BR6348576D0 (en) 1973-07-03
CH414609A (en) 1966-06-15

Similar Documents

Publication Publication Date Title
FR2427M (en) Bacteriotherapeutic drug, in particular for the treatment of gastrointestinal disorders.
FR3069M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR2963M (en) New drug, in particular for the treatment of protein anabolic disorders.
FR3066M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR2323M (en) New drug, in particular for the treatment of follicle-stimulating hyperactivity.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
FR2576M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR3392M (en) Dermatological medicinal product, in particular for the treatment of oozing eczema.
FR1903M (en) New medicament based on an ether which can be used, in particular for the treatment of various solid tumors.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1204M (en) New drug, in particular for the treatment of chronic or post-prandial hyperlipemia.
FR3096M (en) New drug in particular for the treatment of states of adynamia.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR3419M (en) New drugs, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR2656M (en) New drug, in particular for the treatment of chronic or postprandial hyperlipemia.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR2683M (en) New drug, in particular for the treatment of blood coagulability disorders.
FR3526M (en) Therapeutic composition for the treatment of acne.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR1547M (en) New drug, in particular for the treatment of hypophyseal follicle stimulating hyperactivity.
FR1288M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.
FR2885M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.